School of Medicine

Washington University School of Medicine in St. Louis is one of seven U.S. institutions joining a new national clinical trials network launched by the National Cancer Institute, part of the National Institutes of Health (NIH), to investigate emerging technologies for cancer screening, with the goal of reducing cancer-related illnesses and deaths.

Justin B. Serugo, a senior research technician in the Department of Pathology & Immunology at Washington University School of Medicine in St. Louis, died Feb. 6, 2024, in St. Louis following a battle with liver cancer. He was 44.

Neurologist Yo-El Ju, MD, a physician-scientist whose discoveries have illuminated the complex relationship between sleep and neurodegenerative disease, has been named an inaugural Barbara Burton and Reuben M. Morriss III Professor at Washington University School of Medicine in St. Louis.

Three early-career scientists at the School of Medicine have been honored with the Young Physician-Scientist Award by the American Society for Clinical Investigation (ASCI). They are Tarin M. Bigley, MD, PhD; Jeffrey W. Brown MD, PhD; and Drew J. Schwartz, MD, PhD.

GatewaySeq, a genetic test that identifies cancer mutations in solid tumors and that was developed by researchers at Washington University School of Medicine in St. Louis, has been approved for reimbursement by the Centers for Medicare & Medicaid Services.

Two early-career Washington University faculty members have been awarded a prestigious Sloan Research Fellowship: psychologist Zachariah Reagh, in Arts & Sciences, and neuroscientist Gaia Tavoni, at the School of Medicine.

Researchers at Washington University School of Medicine in St. Louis and Lund University in Sweden showed that a blood test is as good at identifying people in early stages of the disease as cerebrospinal fluid tests approved by the Food and Drug Administration for Alzheimer’s diagnosis.

Physicians at Siteman Cancer Center, based at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, will be among the first in the nation to administer a new cell-based immunotherapy to eligible patients with melanoma.

Researchers at the School of Medicine have found important clues to how people make choices involving obtaining information about the future. The scientists identified a set of mental rules that governs decision-making about rewards.

Rajendra Apte, MD, PhD, the Paul A. Cibis Distinguished Professor in the John F. Hardesty, MD, Department of Ophthalmology & Visual Sciences at the School of Medicine, has received a $300,000 Research to Prevent Blindness/American Macular Degeneration Foundation Catalyst Award.